# Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions

> **NCT06589921** · PHASE1 · COMPLETED · sponsor: **Overseas Pharmaceuticals, Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** Pirfenidone Modified-Release Tablets
- **DRUG:** Pirfenidone Tablets

## Key facts

- **NCT ID:** NCT06589921
- **Lead sponsor:** Overseas Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-25
- **Primary completion:** 2023-09-05
- **Final completion:** 2023-09-14
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06589921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06589921, "Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06589921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*